top of page
  • X
  • LinkedIn

Laboratory of Cancer Metastasis and Dormancy

21762_40X_Series029_edited.png

Research

Current cancer therapies often fail to prevent later relapses. Moreover, they fail to treat metastatic disease. We believe that by targeting the sources of those metastases we can prevent metastasis formation. What are these source cells? Our investigation provides evidence that the source of metastasis are cancer cells that have left the primary site (i.e. mammary gland tissue) and arrived at secondary organs such as bones. We have also shown that these disseminated cancer cells (also called DCCs) remain in a non-proliferative state for extended periods of time. We name this non-proliferative state as dormancy. However, upon unknown signals these DCCs start to proliferate and become metastasis. Therefore, if we understand how these cells reactivate we might have a chance to stop these DCCs from becoming a life-threatening metastasis.

Funding

Present

 Pershing Square Sohn Prize Award

CCR/ASPIRE-Susan G. Komen

Gilead’s Research Scholar Programs
R01 NHI/NCI, Principal Investigator
Pilot CTDMI, research award, Albert Einstein College of Medicine

UO1 NCI, co-PIs

21433 NR2F1 CK18 40X_Series011-21433 NR2F1 CK18 40X_Series012_edited.jpg
bottom of page